肾移植术后上尿路梗阻14例临床诊治体会

目的探讨肾移植术后上尿路梗阻的诊断及处理。方法回顾总结2000—2006年我院1090例肾移植患者中的14例移植后上尿路梗阻患者，其中输尿管膀胱吻合口狭窄9例，6例行膀胱输尿管二次吻合手术，1例移植肾周感染输尿管末段坏死采用移植肾近端新鲜存活输尿管与自体输尿管吻合，1例采用膀胱肌瓣代移植输尿管，1例采用输尿管镜下气囊扩张后放置双J管。出血相关性梗阻、输尿管扭曲和输尿管结石所致梗阻5例，均行开放手术。结果14例肾移植术后上尿路梗阻患者中2例切除移植肾，其余各例患者经开放手术及腔镜处理均成功挽救移植肾功能。再次手术后随访0．5—1年，血肌酐68-155μmol／L，B超未见移植肾扩张积水加重。结论新上尿路梗阻是肾移植术后常见亦是较为棘手的外科并发症，多数和外科手术操作有关，可以通过提高手术技巧避免。一旦发生上尿路梗阻，应根据梗阻原因采取相应的治疗方法及时处理。     

移植肾输尿管梗阻的原因与处理方法

目的:探讨移植肾输尿管梗阻的发病原因及其处理方法。方法:报告行肾移植后发生移植肾输尿管梗阻29例的临床资料。全部经手术探查证实,包括输尿管膀胱吻合口狭窄9例,输尿管下段狭窄5例,输尿管全段闭锁2例,膀胱肌层包埋过紧1例,输尿管下段穿孔4例,输尿管全段坏死2例,输尿管下段血块堵塞1例,输尿管外周血肿压迫2例,脓肿压迫1例,移植肾输尿管结石2例。14例移植输尿管坏死患者中有10例梗阻前发生急性排斥反应。结果:患者尿路重建后移植肾功能均恢复良好,随访1年均无再次梗阻发生。结论:移植肾输尿管梗阻以输尿管狭窄和坏死最为多见,排斥反应是发生输尿管梗阻的重要病因之一。对于影像学提示梗阻而移植肾功能无明显受损的病例,应积极行移植肾活检。手术是解决移植肾输尿管梗阻最有效的方法。     

同种异体肾移植术后输尿管狭窄开放手术治疗探讨(附6例报告)

目的 探讨同种异体肾移植术后移植肾输尿管狭窄的手术治疗方案,分析手术治疗效果与临床实用性.方法 2018年4月～2020年11月收治的移植肾输尿管狭窄病人6例.6例均行移植肾造口术和移植肾输尿管膀胱再植术,术后对6例病人进行临床随访.结果 6例病人发生输尿管狭窄为术后1～76个月,平均为术后16.3个月,肾移植术后血肌...     

肾移植术后输尿管并发症17例临床分析

目的 总结肾移植术后输尿管并发症的诊治经验.方法 回顾分析济南军区总医院诊治的17例肾移植术后输尿管并发症患者的临床资料.结果 17例患者伴有不同程度的少尿和局部肿胀不适等症状,实验室检查血清肌酐（Scr）升高,彩色多普勒超声（彩超）检查示移植肾积水、移植肾输尿管扩张,经磁共振水成像或计算机断层摄影术（CT）尿路成像明确诊断.其中输尿管膀胱吻合口狭窄15例,输尿管坏死2例.治疗经过：14例行开放性手术,包括行移植肾输尿管膀胱重新吻合术12例,移植肾输尿管-自体输尿管吻合1例,移植肾输尿管游离、重新放置输尿管支架管1例.3例行非开放性手术治疗,包括输尿管皮肤造瘘1例、腔内球囊导管扩张术1例、软膀胱镜下逆行输尿管支架管插管治疗1例.疗效：14例开放手术治疗患者与1例输尿管皮肤造瘘患者的移植肾肾盂与膀胱的连接部恢复通畅,移植肾功能均明显改善.另2例非开放手术治疗患者,包括1例腔内球囊导管扩张术及1例行软膀胱镜下逆行输尿管支架管插管术患者术后复发,行开放手术治疗.结论 彩超及磁共振成像水成像或CT尿路成像等影像学检查是确诊移植肾输尿管并发症的主要方法.肾移植术后输尿管并发症应以预防为主,确诊后视具体情况行开放性手术或非开放性手术治疗,开放手术治疗的疗效较佳.     

移植肾动脉血管瘤破裂一例

患者，男性，42岁。因患“尿毒症”于1996年在外院行第1次尸肾移植，术后移植肾功能未恢复，继续血液透析治疗。2000年1月行第2次尸肾移植，手术顺利，1周后移植肾功能恢复正常，2周后出院。出院后服用免疫抑制剂并定期复查。于2003年12月底因移植肾功能不全，来我院门诊行B型超声波及核磁共振水成像检查，结果提示：输尿管膀胱吻合口处狭窄。拟行移植肾输尿管探查，但被患者拒绝。2004年3月，     

开放手术治疗肾移植术后输尿管梗阻的技术探讨

目的探讨肾移植术后移植肾输尿管狭窄的开放手术技巧与效果。方法首都医科大学附属北京友谊医院泌尿外科于2019年1月—2020年1月共行166例单肾移植,共发生5例肾移植术后输尿管狭窄,根据梗阻部位的不同采用了不同的开放手术术式进行治疗,回顾性分析这组患者的临床资料及预后。结果5例患者中,男性3例,女性2例,平均年龄42.6岁。其中2例患者原发病为Ⅱ型糖尿病,3例患者为肾小球肾炎。输尿管梗阻确诊的平均时间为肾移植术后143.8 d,行开放手术平均时间为肾移植术后209.8 d,确诊梗阻时平均血肌酐水平为271.94μmol/L。所有患者均因出现移植肾积水合并血肌酐进行性升高经影像学检查确诊,首先采取内支架或经皮肾造瘘紧急挽救肾功能。待肾功能恢复稳定后,根据梗阻段位置,3例患者行移植输尿管-膀胱再吻合术,1例患者行原输尿管-移植肾输尿管端端吻合术,1例患者行膀胱皮瓣翻转代输尿管术。5例患者开放手术平均时间为2.6 h,术中平均出血量为32 ml。开放手术后,5例患者均预后良好,开放手术后平均血清肌酐恢复至111.5μmol/L,尿量正常,无外科并发症发生。随访半年后,5例患者均未再发生输尿管梗阻。结论移植肾输尿管梗阻是肾移植术后常见外科并发症之一,腔内治疗中远期效果有限,根据不同梗阻部位选择不同术式进行开放手术,是治疗移植肾输尿管狭窄的有效方案。     

肾移植术后长段输尿管狭窄的诊断与开放性手术治疗

目的 总结肾移植术后发生长段输尿管狭窄的诊断方法与手术治疗经验.方法 分析11例肾移植术后发生长段输尿管狭窄患者的临床资料.患者发生长段输尿管狭窄的时间为肾移植术后2～6个月,临床表现为血肌酐升高、体重增加、尿量减少和移植肾区肿胀.所有患者均经B型超声、64层螺旋CT尿路造影(CTU)或磁共振尿路水成像(MRU)确诊,输尿管狭窄长度为3～7 cm.11例患者的治疗方法为:5例行膀胱壁瓣输尿管成形术;2例行供肾肾盂-自体输尿管吻合术;4例行供肾输尿管-自体输尿管吻合术.结果 11例长段输尿管狭窄的患者经开放性手术治疗后,均取得成功,恢复了尿路的通畅.手术时间为2.5～4 h,无明显手术并发症.术后尿量显著增加,血肌酐下降至75～156μmol/L,B型超声示移植肾积水明显减轻或消失.术后随访8～62个月,患者肾功能稳定,无再发狭窄.结论 对肾移植术后出现血肌酐升高等临床特点的患者,应考虑到输尿管狭窄的可能,及时采用B型超声进行常规的检查,采用CTU或MRU明确狭窄的长度及部位;明确诊断后应及时进行开放性手术治疗.肾移植术后的长段输尿管狭窄经早期诊断和及时治疗成功率较高.     

肾移植术后尿路梗阻的诊治体会

目的 探讨肾移植术后尿路梗阻的原因,总结诊断和治疗经验.方法 回顾性分析我院1996年2月至2010年12月收治的14例肾移植术后尿路梗阻患者的临床资料.12例患者因血清肌酐进行性升高发现尿路梗阻,2例因尿瘘、尿外渗发现.均行开放手术治疗,术中发现输尿管末段狭窄,行输尿管膀胱吻合术.结果 所有患者移植肾功能于术后1～3周明显改善,移植肾积水于术后3～6周渐恢复.随访期间未见有尿路梗阻致移植肾积水.结论 尿路梗阻是肾移植术后严重并发症,加强围手术期管理,术中精细操作可有效预防其发生.超声和磁共振尿路成像对诊断有较大帮助.积极治疗可有效延长移植肾的存活,具有重要临床意义.     

移植肾输尿管梗阻的诊断与治疗：（附13例报告）

为了提高对移植肾输尿管梗阻患者的诊断与治疗水平，对在５３６例次肾移患者中发现的１３你输尿管梗阻患者进行临床总结分析，其中输尿管狭窄性梗阻１０例，输尿管结石性梗阻３例。分析认为，肾移植术后早期排斥反应、伤口深部感染及漏尿可能与发生移植肾输尿管狭窄性梗阻有关，而肾移植术后高尿酸血站与输尿管结石形成有关。提出Ｂ超、肾图、经皮顺行造影和肾盂内压测定为诊断移植肾输尿管梗阻的手段；对于输尿管狭窄性梗阻患者，早     

输尿管镜手术中输尿管完全撕脱伤的处理

目的:本文旨在分析输尿管镜手术中发生输尿管两端完全撕脱伤的原因及治疗方式,并探讨可能的预防措施。方法:回顾性分析急诊接诊的输尿管镜手术中发生输尿管两端完全性撕脱伤的3例病例,并对其发生原因、处理方式及预防措施进行探讨。结果:3例均为男性患者,术中观察到输尿管壁内段存在相对狭窄,进镜过程中受阻,用力推进输尿管镜时阻力消失;随后在退镜操作时均发现存在阻力,输尿管镜无法撤出,用力退镜时发生输尿管撕脱伤。1例术中探查见输尿管两端完全性撕脱,近端位于肾盂输尿管交界处(UPJ)下方约1.0cm处,远端位于输尿管膀胱交界处(UVJ)处,行左侧肾脏切除术;1例术中探查见输尿管两端完全性撕脱,近段位于UPJ下方约4.0cm处,远端位于UVJ处,行Boari膀胱瓣术;1例术中行输尿管镜探查见输尿管远端于UVJ处离断,改行左侧经皮肾镜手术探查见近段输尿管于UPJ下方约2.0cm处离断,遂行左肾造瘘术,术后1周行回肠代输尿管手术。3例患者均完成术后随访3~6个月。结论:输尿管壁内段相对狭窄是发生输尿管两端完全性撕脱伤的高危因素,操作不当是发生输尿管两端完全性撕脱伤的直接原因。损伤发生后,应根据患者病情和生理解剖等因素制定适当手术方式。输尿管壁内段相对狭窄存在时,应高度警惕发生输尿管撕脱伤的可能。     

Improved renal transplantation in the rat with a nonsplinted ureteroureterostomy

Orthotopic renal transplantation in the rat is a widely used model in immunology and transplantation-related research. Although numerous modifications of the surgical technique of ureteric reconstruction were evaluated, ureter complications following this reconstruction still occurred frequently. Instead of dividing the ureter in the middle between kidney and bladder (method 1), the anastomosis was performed close to the renal pelvis after cutting the ureter obliquely (method 2), which enlarged the diameter of the ureteral anastomosis 2-fold. The incidence of stenosis of ureteric anastomosis was 12.5% (3/24) using method 1, whereas this complication was avoided completely (0/45) using method 2. Furthermore, the risk of injury to the ureter was reduced, as isolation of the ureter was limited. These modifications improved the last delicate step in the procedure of rat kidney transplantation.     

Results of pyeloureterostomy after ureterovesical anastomosis complications in renal transplantation

OBJECTIVES: The most frequent urologic complications after renal transplantation involve the ureterovesical anastomosis (ie, leakage, stenosis, and reflux), with a frequency of 1% to 30% in different series. We present the results of pyeloureterostomy using the recipient's ureter. METHODS: From 1988 to 1996, 570 cadaveric renal grafts were performed at our institution. A Lich Gregoir ureterovesical anastomosis was used in every case. Complications involving the anastomosis occurred in 19 cases (3.3%), with 10 stenoses (1.7%), 6 cases of leakage (1.1%), and 3 of reflux (0.5%). The mean donor age was 36.2 years, and the mean duration of cold ischemia was 29.4 hours. The mean recipient age was 41.3 years. Corrective surgery was performed 0.09 years (range 0.01 to 0.22) after transplantation for leakage, 1.13 years (range 0.14 to 5.11) for stenosis, and 5.55 years (range 0.51 to 9.71) for reflux. The recipient's ureter was stented with a ureteral catheter before median laparotomy, except in 3 cases of early leakage (less than 3 days). The recipient's ureter was cut, without the need for ipsilateral nephrectomy, and sutured to the graft pelvis. A nephroureterostomia stent (Gil Vernet stent) (12 cases) or a double J ureteral stent (7 cases) was used for urinary drainage. RESULTS: One graft was lost on day 1 through renal vein thrombosis. Percutaneous nephrostomy was performed on day 2 to clear an obstruction of the double J ureteral stent in one case, and a double J ureteral stent was inserted on day 2 because the nephrouretrostomia stent was incorrectly positioned in another case. Pyelographic controls on day 15 were normal in every case. The mean follow-up was 2.25 years (range 0.24 to 6.1) (2.9 years for leakage, 2.08 years for stenosis, and 1.44 years for reflux). One patient died with a functional graft 3 years after surgery. One graft was lost 4 years after surgery through chronic rejection. There were no complications affecting the ipsilateral kidney. No further ureteral complications occurred after surgery. The mean creatinine level 3 years after surgery was 1.59 mg/dL. CONCLUSIONS: Pyeloureterostomy is a safe and permanent treatment for complications of ureterovesical anastomosis and gives excellent results. The technique requires stenting of the recipient's ureter and graft drainage with a nephroureterostomia stent or a double J ureteral stent.     

移植肾输尿管上段并发症的处理四例

目的 探讨移植肾输尿管上段并发症的处理方法。方法 4例不同原因所致的移植肾输尿管并发症，在无法行膀胱输尿管吻合的情况下，经腹腔或腹膜外途径。将受者输尿管与供肾肾盂吻合，内置双“J”管，经过充分的内，外引流，达到治疗输尿管病变的目的。结果 4例中有3例可正常排尿，1例尚需进一步治疗，随访2个月至1年，人，肾存活良好。结论 对于移植肾输尿管上端病变，采用自身输尿管与供肾肾盂吻合是一种处理较复杂移植肾输尿管病变的好方法。     

Experiences in kidney transplantation with duplicated ureters

INTRODUCTION: The purpose of this study was to evaluate the complications of duplicated ureters in renal transplant recipients. METHODS: Between 1983 and 2004, 12 patients (median age 34 years) received renal transplants from donors with duplicated ureters. In four patients the ureter to bladder anastomoses were performed separately according to the method described by MacKinnon, including two cases transplanted with ureteral catheters because of narrow widths. In the following cases of eight duplicated ureters an anastomosis was performed between the distal part of each ureter to form a common ureteral ostium, which was connected to the urinary bladder. A ureteral catheter was used to the splint ureterovesical anastomosis. RESULTS: No graft loss to ureteral complications was observed. There was no ureteral necrosis in the postoperative period. No clinical symptoms of ureteral junction obstruction were revealed after removing the ureteral catheter. By ultrasound examination four patients showed a slight temporary pyelocaliectasis was observed and four patients developed temporary urinary fistulas. CONCLUSION: Our ureterocystoneostomy procedures with duplicated ureters were safe and useful in kidney transplantation.     

自体肾盂输尿管在肾移植术中的应用

目的 报告自体肾盂输尿管在肾移植术中的应用。方法 应用自体肾盂输尿管治疗各种移植肾输尿管并发症18例，男13例，女5例，年龄28～56岁，平均42岁。10例尿瘘患者，3例行自体输尿管与移植肾盂成形术，2例行自体输尿管与移植肾输尿管吻合术，5例行自体肾盂移植、肾盂成形术；5例移植肾输尿管过短术中均行自体输尿管与移植肾输尿管吻合术；3例移植肾输尿管狭窄均行自体输尿管与移植肾输尿管吻合术。结果 术后随访3个月～8年，2例因慢性排斥反应，移植肾失功，余16例移植肾功能正常。结论 自体肾盂输尿管是治疗某些肾移植后输尿管并发症的一种有效方法。     

Surgical complications in kidney transplantation in nonhuman primates

Surgical complications are important causes of graft loss in the nonhuman primate kidney transplantation model. We reviewed the incidence and intervention methods in 182 kidney transplantations performed in our lab recently 2 years in Cynomolgus monkeys. There were six renal artery thromboses (3.3%), eight urine leakages (4.4%), and five ureteral stenoses (2.7%). All renal artery thrombosis cases were found within 3 days after surgery. Urine leakage appeared from the 5th to 12th day after surgery and all cases were caused by ureter rupture. Reexploration was performed in five cases to reanastomose ureter with stent. Four cases reached long‐term survival. The rest one died of graft rejection. Ureteral stenoses were found in long‐term survival cases. Ureter reanastomoses with stent were performed in two cases. The postoperative renal functions of these two monkeys recovered to normal and they survived until study termination. From this large number of study, our experience indicated that kidney transplantation in the nonhuman primate is a safe procedure with low complications. Reexploration is recommended for salvage of the graft with urine leakage and ureteral stenosis. © 2010 Wiley‐Liss, Inc. Microsurgery, 2010.     

The use of long-term defunctionalized bladder in renal transplantation: is it safe?

OBJECTIVE: Evaluation of the use of defunctionalized bladder in renal transplantation, concerning surgical complications. METHODS: In order to assess the complication rate of ureteral reimplantation in long-term defunctionalized bladder, we compared 20 patients on haemodialysis for more than 15 years (group I) with another 20 patients on haemodialysis for less than 5 years (group II). None of these patients had renal failure due to urological causes or neurogenic bladder. Non-stented extravesical ureteroneocystostomy was done routinely in all patients except 1 in group II who underwent Politano-Leadbetter ureteroneocystostomy and 7 patients in group I who underwent Politano-Leadbetter (3 patients) and pyelo-ureteral anastomosis using the recipient's native ureter (4 patients). The amount of residual urine was insignificant (<100 cm(3)) in both groups. RESULTS: The mean postoperative bladder catheterization period was 7.8 days in group I and 4.2 days in group II. Postoperative urinary tract infections were observed in 9 cases of group I and in 4 cases of group II. No surgical complications occurred in patients of group II, while there were 6 patients with surgical complications in group I: stenosis after a pyelo-ureteral anastomosis (1 case), stenosis after a ureterovesical anastomosis with Politano-Leadbetter technique (1 case), urinary fistulae (3 cases; 1 with Politano-Leadbetter ureteroneocystostomy and 2 cases with pyelo-ureteral anastomosis), and vesico-ureteral reflux (1 case with Politano-Leadbetter ureteroneocystostomy). These 6 cases had the lowest bladder capacity (30-150 cm(3)) among our 40 patients. Graft losses were comparable between the two groups and were not due to surgical complications. CONCLUSION: Small defunctionalized bladders can be used in kidney transplantation, but it may represent an increased surgical risk due to difficulty in performing ureteral reimplantation.     

The treatment of fistulae and ureteral stenosis after kidney transplantation

INTRODUCTION: The incidence of urological complications after kidney transplantation varies from 3% to 14%, with a probable loss of the graft in 10% to 15% of cases and a mortality rate of up to 15%, despite improvements in prevention, diagnosis, and treatment as well as the use of new immunosuppressive therapies. Urinous fistulae, which are considered early complications of transplantation, are due to ischemic damage or necrosis generally occurring in the distal third of the ureter. Preservation of accessory arteries to the lower portion of the kidney is important, as they may constitute the blood supply of this segment of the collecting system or ureter. Their ligation may lead to necrosis and urinary fistulae. Ureteral stenosis, as late complication, is related to a pathology of the ureter itself, to infections, to abscesses, to fibrosis, and to ischemia. An early endoscopic approach permits resolution in 70% of cases. The aim of this retrospective study was to determine incidence and treatment of these complications. MATERIALS AND METHODS: From 1991 to 2004 we performed 453 kidney transplantations both from cadaveric and living donors. In 199 patients we performed a transvesical ureteroneocystostomy (UNCS), and in 260, an extravesical UNCS. RESULTS: The nine patients who showed fistulae (1.9%) underwent surgical treatment. In eight we used a direct ureteral reimplantation, and in one, a Boari flap technique. Nephrectomy was necessary in four patients, including two who died of septic complications. In all 26 cases of ureteral stenosis (5.6%), we used an endourological approach (anterograde or retrograde), with surgical treatment afterward in 11 patients (42%) nine direct reimplants, one anastomosis to the native ureter (transplantation from a living donor), and in one case a Boari flap technique four patients who underwent surgical treatment showed progressive damage to graft function. CONCLUSIONS: In all patients who showed fistulae we suggest surgical review: for patients with ureteral stenosis, we suggest first an endourological approach and only when it is not successful do we consider surgical treatment.